Live Breaking News & Updates on Lupin

Stay informed with the latest breaking news from Lupin on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lupin and stay connected to the pulse of your community

Lupin stocks: Buy Lupin, target price Rs 1770: Axis Securities

Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Services, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2023.

Economic-times , Lupin-stocks , Markets , Market-news , Sensex , Nifty , Lupin , Lupin-ltd , Lupin-ltd- ,

Lupin Share Price: Lupin stock price up 0.62 per cent as Sensex climbs

As of 31-Mar-2024, promoters held 46.73 per cent stake in the company, while FIIs held 18.28 per cent and domestic institutional investors had 16.82 per cent.

Lupin-ltd , Relative-strength-index , Lupin , Lupin-ltd- , Lupin-share-price , Bse , Nse , Nifty , Sensex , Stocks-in-news ,

Lupin Share Price: Lupin shares decline 0.22% as Sensex climbs

A total of 29,028 shares changed hands on the counter till 10:56AM (IST)

Lupin-ltd , Lupin , Lupin-ltd- , Lupin-share-price , Bse , Nse , Nifty , Sensex , Stocks-in-news ,

Reliance tops India Involved Ranking 2023; underlines its commitment to Viksit Bharat

Reliance Industries has secured the top position in the India Involved Ranking 2023, which assesses the commitment of Indian corporations to Viksit Bharat. Compiled by Skoch, the ranking and index result from a meticulous six-month study. The evaluation involved analyzing numerous companies across 231 indicators to determine the top 20 corporates in the comprehensive 'India Involved Ranking'.

New-delhi , Delhi , India , Hindustan , India-general- , Mukesh-ambani , Viksit-bharat , Vikasit-bharat , Indian-school-of-business , Adani-group , Offering-college , Aditya-birla-health-insurance

Lupin receives Establishment Inspection Report from USFDA for its Aurangabad manufacturing facility

The inspection was conductedfrom March 6 to March 15, 2024. The U.S. FDA has determined that the inspection classification ofthe facility is Voluntary Action Indicated (VAI)

Aurangabad , Maharashtra , India , United-states , Nilesh-gupta , Drug-administration , Board-of-directors-the-company , Lupin-limited-on , Voluntary-action-indicated , Lupin-limited , Establishment-inspection-report , United-states-food

Experts bet on these 10 stocks that may outperform market with healthy returns

Experts say 22,300 is expected to be crucial hurdle for further upside in the Nifty 50 as the closing above can lift the index towards 22,500 mark

India , Mazagon , Maharashtra , Titagarh , West-bengal , Bharat , Nagaraj-shetti , Riyank-arora , Osho-krishan , Amol-athawale , Subash-gangadharan , Steel-authority-of-india

Lupin Share Price: Share price of Lupin jumps as Sensex gains 199.07 points

A total of 14,797 shares changed hands on the counter till 10:05AM (IST)

Lupin-ltd , Lupin , Lupin-ltd- , Lupin-share-price , Bse , Nse , Nifty , Sensex , Stocks-in-news ,

Lupin launches generic drug in US market

The Mumbai-based drug maker has introduced the medication after receiving an approval from the US Food and Drug Administration (USFDA), Lupin said in a statement.

Mumbai , Maharashtra , India , Drug-administration , Astellas-pharma-global-development-inc-myrbetriq , Astellas-pharma-global-development , Business , Companies , Lupin , Us-market ,

Dateline

Dateline
vimarsana.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vimarsana.com Daily Mail and Mail on Sunday newspapers.

Metropolitan-area , Metropolis , Urban-area , Landmark , City , Building , Skyscraper , People , Commercial-building , Human-settlement , Architecture , Tower-block